Chronic Thalidomide and Chemoembolization for Hepatocellular Carcinoma

BACKGROUND. Transcatheter arterial chemoembolization (TACE) has been used to curtail tumor vasculature and delay tumor progression in hepatocellular carcinoma (HCC). We conducted a phase I trial to evaluate the efficacy and toxicity of thalidomide when combined with TACE in patients with advanced HC...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncologist
Main Authors: Wu, Jennifer, Ng, Jennifer, Christos, Paul J., Goldenberg, Alec S., Sparano, Joseph, Sung, Max W., Hochster, Howard S., Muggia, Franco M.
格式: Artigo
語言:Inglês
出版: AlphaMed Press 2014
主題:
Clinical Trial Results
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257750/
https://ncbi.nlm.nih.gov/pubmed/25361625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0283
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍